We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$111M
1-Year Est. Return
74.4%
This Fund
S&P 500
This Quarter
Est. Return
-6.02%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$1.53B
AUM Growth
-$325M
(-18%)
Cap. Flow
+$93M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
65.86%
Holding
300
New
43
Increased
68
Reduced
83
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$95.6M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
+$7.45M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$5.41M |
| 4 |
Microbot Medical
MBOT
|
+$4.73M |
| 5 |
United Therapeutics
UTHR
|
+$4.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.09M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$5.39M |
| 3 |
MTFB
Motif Bio plc ADRs
MTFB
|
+$4.6M |
| 4 |
OTIC
Otonomy, Inc.
OTIC
|
+$3.19M |
| 5 |
Palisade Bio
PALI
|
+$2.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.02% |
| 2 | Healthcare | 13.32% |
| 3 | Materials | 0.27% |
| 4 | Technology | 0.24% |
| 5 | Financials | 0.11% |
Similar funds
IWA
BFA
WPWM
BCM
ZS
KC
FI
CIM
Sabby Management's Q2 2017 Portfolio in Review
As of Q2 2017, Sabby Management held 300 positions worth $1.53B, down 18% from $1.85B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Sabby Management deployed $93M of net new capital in Q2 2017, opening 43 new positions and adding to 68 existing holdings. Its largest new stake was TESARO, Inc.: 51,426 shares worth $7.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 93% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Otonomy, Inc., an estimated $3.19M trimmed.
- Sabby Management's largest Q2 2017 buy was TESARO, Inc.: 51,426 shares worth $7.19M.
- Sabby Management added most to Bristol-Myers Squibb in Q2 2017, an estimated $95.6M increase.
- Sabby Management's biggest Q2 2017 reduction was Otonomy, Inc., cutting an estimated $3.19M.
- Sabby Management fully exited Amgen in Q2 2017, selling an estimated $6.09M.
- Sabby Management's ten largest holdings make up 66% of its $1.53B portfolio in Q2 2017.
- Sabby Management opened 43 new positions and closed 84 in Q2 2017.
- Sabby Management's portfolio value fell 18% quarter-over-quarter to $1.53B.
Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.